FCGR3A and amyotrophic lateral sclerosis: Here we tested this hypothesis by first applying the N-glycome approach and then by demonstrating over-expression of CD16 and co-localization of ALS-IgG with CD16 in sections of brain and spinal cord tissues from 130- and 75-day old G93A-SOD1 mice.